2000 Data Patients Treatment 
Veriheal
OCTOBER 29, 2020
billion was funded into cannabis research between 2000 and 2018. On the brighter side, Science Magazine has indicated that the funding for cannabis as an effective form of treatment and therapy is rising, however not as much as the funding for its adverse impacts are. How could we move the focus towards understanding the benefits?
The Cannigma
AUGUST 5, 2022
Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Blunt Truth
AUGUST 13, 2019
The public hearing attracted over 100 speakers and 2000 participants. To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”. The FDA is collecting data to fill these gaps.
Veriheal
OCTOBER 5, 2020
The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it. The Hawaiian cannabis regulations also allow caregivers to take on the responsibility for managing the cannabis consumption and cultivation of the cannabis qualifying patient.
Cannabis Law Report
SEPTEMBER 12, 2021
Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Nevada voters approved medical marijuana for people by ballot initiative in 2000. But do medical cannabinoids actually help animal patients? Earlier this year, Gov. A simple question.
The Cannigma
FEBRUARY 11, 2021
One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. Why cannabis?
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.
Expert insights. Personalized for you.
98 
Let's personalize your content